Unaudited Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Common Stock 5.75% Convertible Notes	Additional Paid-in Capital	Additional Paid-in Capital 5.75% Convertible Notes	Accumulated Losses	Noncontrolling Interest	AOCI Attributable to Parent	Treasury Stock
Beginning Balance at Dec. 31, 2018		$ 11		$ 1,037,372		$ (312,796)	$ 26,999	$ (53,068)	$ (844,253)
Beginning Balance (in shares) at Dec. 31, 2018		11,162
Shares issued on vesting of restricted stock (in shares)		95
Shares issued on conversion of 5.75% Convertible Notes	$ 6,229		$ 4		$ 6,225
Shares issued on conversion of 5.75% Convertible Notes (in shares)		3,727
Foreign currency translation				(76)				(4,647)
Re-purchase of Umbro China Equity				(770)			(495)
Change in redemption value of redeemable non-controlling interest				1,586
Equity compensation expense				760
Reclass from redeemable NCI							(856)
Net (loss) income	5,494					(16,492)
Distributions to joint ventures							(9,409)
Shares repurchased on vesting of restricted stock									(81)
Ending Balance (in shares) at Sep. 30, 2019		14,984
Ending Balance at Sep. 30, 2019	(164,492)	$ 15		1,045,097		(329,288)	21,733	(57,715)	(844,334)
Beginning Balance at Jun. 30, 2019		$ 15		1,045,518		(293,580)	22,612	(53,671)	(844,334)
Beginning Balance (in shares) at Jun. 30, 2019		14,928
Shares issued on conversion of 5.75% Convertible Notes					$ 46
Shares issued on conversion of 5.75% Convertible Notes (in shares)		56
Foreign currency translation				(59)				(4,044)
Re-purchase of Umbro China Equity				(770)			(495)
Equity compensation expense				362
Net (loss) income	895					(35,708)
Distributions to joint ventures							(1,279)
Ending Balance (in shares) at Sep. 30, 2019		14,984
Ending Balance at Sep. 30, 2019	(164,492)	$ 15		1,045,097		(329,288)	21,733	(57,715)	(844,334)
Beginning Balance at Dec. 31, 2019	(256,359)	$ 15		1,045,307		(429,117)	26,521	(54,643)	(844,442)
Beginning Balance (in shares) at Dec. 31, 2019		15,138
Shares issued on vesting of restricted stock (in shares)		196
Shares issued as payment of interest on 5.75% Convertible Notes	1,316	$ 1		1,422
Foreign currency translation								5,713
Change in redemption value of redeemable non-controlling interest				(171)
Equity compensation expense				609
Net (loss) income	5,335					6,808
Distributions to joint ventures							(5,550)
Shares repurchased on vesting of restricted stock									(84)
Ending Balance (in shares) at Sep. 30, 2020		16,650
Ending Balance at Sep. 30, 2020	(242,276)	$ 16		1,047,167		(422,309)	26,306	(48,930)	(844,526)
Beginning Balance at Jun. 30, 2020		$ 15		1,045,408		(468,035)	27,464	(54,666)	(844,526)
Beginning Balance (in shares) at Jun. 30, 2020		15,334
Shares issued as payment of interest on 5.75% Convertible Notes	1,316	$ 1		1,423
Foreign currency translation								5,736
Change in redemption value of redeemable non-controlling interest				140
Equity compensation expense				196
Net (loss) income	595					45,726
Distributions to joint ventures							(1,753)
Ending Balance (in shares) at Sep. 30, 2020		16,650
Ending Balance at Sep. 30, 2020	$ (242,276)	$ 16		$ 1,047,167		$ (422,309)	$ 26,306	$ (48,930)	$ (844,526)